Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Return on Assets (2016 - 2025)

Historic Return on Assets for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to 0.12%.

  • Dexcom's Return on Assets rose 300.0% to 0.12% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12%, marking a year-over-year increase of 300.0%. This contributed to the annual value of 0.13% for FY2025, which is 400.0% up from last year.
  • Per Dexcom's latest filing, its Return on Assets stood at 0.12% for Q4 2025, which was up 300.0% from 0.1% recorded in Q3 2025.
  • Dexcom's Return on Assets' 5-year high stood at 0.14% during Q2 2021, with a 5-year trough of 0.04% in Q4 2021.
  • In the last 5 years, Dexcom's Return on Assets had a median value of 0.08% in 2023 and averaged 0.08%.
  • Data for Dexcom's Return on Assets shows a peak YoY increase of 700bps (in 2021) and a maximum YoY decrease of -900bps (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Dexcom's Return on Assets stood at 0.04% in 2021, then surged by 48bps to 0.07% in 2022, then grew by 27bps to 0.08% in 2023, then rose by 7bps to 0.09% in 2024, then soared by 35bps to 0.12% in 2025.
  • Its Return on Assets was 0.12% in Q4 2025, compared to 0.1% in Q3 2025 and 0.08% in Q2 2025.